FDA Inspection 1173805 — Christopher P. Recknor MD
The FDA completed an inspection of Christopher P. Recknor MD on June 10, 2022 in Gainesville, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 10, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Gainesville, GA (United States)
Additional Details
Clinical Investigator (CI)